Find a TenderAwarded without competitionContract details notice
Published 15 Jul 2026, 13:36 BST

Official UK procurement notice

Purchase of Alternating Tangential Flow (ATF) Non-GMP Equipment

Official notice

Authority: Cell & Gene Therapy Catapult (Public body)

Direct award
Budget not disclosedValue not published
Awarded 22 Jul 2026no call for competition
Awarded to Repligen B.V

What is being bought

Published requirement description

CGTC Braintree plans to procure Non-GMP Alternating Tangential Flow (ATF) equipment to support process development activities that will subsequently be transferred to GMP manufacturing. The procurement includes a one year equipment warranty and the option to enter into an additional one-year service contract. The total value of the procurement is €254,479 (excluding VAT).

The lotProcurement structure

single lot · no lot value published

Procedure terms & legal framework

From the official record
Procedure method
Direct award
Legal basis
UKPGA · 2023/54 Procurement Act 2023
Notice status
Awarded without competition
Procurement threshold
Unspecified in notice
Regulatory regime
Standard
Commercial structure
Stand-alone contract (no framework)
Competition type
Direct award (no call for competition)
GPA / WTO covered
Unspecified in notice
Recurring procurement
Unspecified in notice
First published
15 Jul 2026, 13:36 BST
Last source update
13 Oct 2026, 12:24 BST
Authority reference
DA0040BMIC
FTS notice number
2026/S 000-096501
Latest notice
Contract details notice (UK7)
Delivery area
Not published
Official registry OCID
ocds-h6vhtk-06cbf5 Find a Tender
Why no open competition
Single Suppliers Technical Reasons
Published justification

Schedule 5, paragraph 6 of the Procurement Act 2023 provides for the following justification for directly awarding contracts where there is only a single supplier who can meet the requirement:

"The following conditions are met in relation to the public contract-

(a)due to an absence of competition for technical reasons, only a particular supplier can supply the goods, services or works required, and

(b)there are no reasonable alternatives to those goods, services or works."

This purchase is for a lab base non-GMP system, but it is required to support the development of the process that will be transferred to GMP Manufacturing. A Repligen system will be used in GMP Manufacturing for the reasons listed below, and therefore the corresponding smaller scale lab system is required for this purchase.

Repligen are the only supplier of GMP Perfusion equipment that operates using Alternating Tangential Flow. There is no other commercially available system that can perform single use ATF style perfusion suitable for use in a GMP cleanroom. ATF style perfusion has been selected for this project as it is technically superior to the alternative TFF (Tangential Flow Filtration)-based or acoustic-based perfusion devices and there is wider industry adoption of ATF for use in bio-therapeutic manufacturing operations for this reason.

Alternative suppliers found from online searches have single-use TFF systems available such as the Sartorius Sartoflow 5000 SU TFF System, but these are not suitable for use in perfusion applications and are not proven to readily connect with Thermo Fisher Dynadrive bioreactors. Extensive re-engineering of BMIC existing systems would need to take place in order to interface these devices and even then it is unlikely to achieve the process intensity outputs required for a suitable reduction in the

cost of goods.

Notice history

4 events · 3 releases on Find a Tender · since 15 Jul 2026
  1. Transparency notice published
    15 Jul 2026, 13:36 BST
    UK5
  2. Contract award notice published
    22 Jul 2026, 10:17 BST
    UK6
  3. Contract signature expected
    4 Aug 2026, 23:59 BST
    scheduled
  4. Contract details notice published
    13 Oct 2026, 12:24 BST
    UK7

Commercial outcome & contract awards

Published awards, contracts and bid statistics, not a forecast
Awards 1
Contracts signed 1latest 29 Sept 2026
Awarded toValueDateStatus
Repligen B.V13 Oct 2026 – 12 Oct 2027 · up to 12 Oct 2028Extensions: The procurement includes and option to enter an additional 1 year service contract. · Options: Option to purchase a 1 year service contract after the warranty period expires. There is also the option to purchase spare parts for equipment maintenance,€288,23222 Jul 2026Awarded

Contracts

  • Contract 1 · Repligen B.V

    Signed
    29 Sept 2026
    Value
    €254,479
    Period
    29 Sept 2026 – 23 Oct 2027
    Status
    active

    No agreed KPIs: KPIs have not been established for this contract because it is a one off purchase, rather than an ongoing service contract requiring continuous performance monitoring. In addition, the contract value is below the threshold at which KPIs are required under Section 52 of the Procurement Act 2023, therefore, KPIs are not considered appropriate for the nature of this contract.

Contracting authority & participating public bodies

CELL THERAPY CATAPULT LIMITED

Contracting authorityPublic authority - sub-central government GB-COH: 07964711 · GB-PPON: PNLN-8116-PBCH 12th Floor Tower Wing B, London, London, SE1 9RTContact email

Bidders & participating suppliers

1 commercial party on the notice
  • Repligen B.VAwarded supplierGB-PPON: PJVY-1337-QRCH Hoeksteen 13, Breda, NL, 4815 PR, NLContact email

Official documents & specifications (3)

Official links; attachments are not copied

Notices published for this procedure

  • Contract details notice contractContract details noticeUK7Contract details notice on Find a Tender
  • Contract award notice awardContract award noticeUK6Contract award notice on Find a Tender
  • Transparency notice awardTransparency noticeUK5Transparency notice on Find a Tender